IPCI

Intellipharmaceuticals International Inc.
IPCI

Overview Fund Activity
Delisted

IPCI was delisted on the 20th of March, 2019.

Back to rankings

25 hedge funds and large institutions have $3.99M invested in Intellipharmaceuticals International Inc. in 2018 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 4 closing their positions.

Holders
25
Holders Change
–
Holders Change %
0%
% of All Funds
0.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
3
Reduced
4
Closed
4
Calls
$8K
Puts
–
Net Calls
+$8K
Net Calls Change
+$19K

Top Buyers

1
BFM
1
Boothbay Fund Management
New York
$17K
2
TSS
2
Two Sigma Securities
New York
$12K
3
UBS Group
3
UBS Group
Switzerland
$10K
4
Barclays
4
Barclays
United Kingdom
$13K
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$7K

Top Sellers

1
AFM
1
Anson Funds Management
Texas
$0
2
VF
2
Virtu Financial
New York
$0
3
BAM
3
Belpointe Asset Management
Nevada
$0
4
Morgan Stanley
4
Morgan Stanley
New York
$10K
5
Group One Trading
5
Group One Trading
Illinois
$0
Name Market Value Shares Shares
Change 		Shares
Change %
LTFS
26
Ladenburg Thalmann Financial Services
Florida
$0 13 – –
Bank of America
27
Bank of America
North Carolina
$0 6 – –
SEI Investments
28
SEI Investments
Pennsylvania
$0 4 – –
Wells Fargo
29
Wells Fargo
California
$0 29 +1 +4%
Simplex Trading
30
Simplex Trading
Illinois
$0 1,200 +1,200 New
1
2